Avadel Pharmaceuticals PLC
Change company Symbol lookup
Select an option...
AVDL Avadel Pharmaceuticals PLC
ACEL Accel Entertainment Inc
USLM United States Lime & Minerals Inc
BWEN Broadwind Inc
EQIX Equinix Inc
TXMD TherapeuticsMD Inc
ORC Orchid Island Capital Inc
GBX Greenbrier Companies Inc
FCX Freeport-McMoRan Inc
TRKA Troika Media Group Inc
Go

Health Care : Pharmaceuticals |
Based in Ireland
Company profile

Avadel Pharmaceuticals plc is a biopharmaceutical company. The Company’s lead product candidate, FT218, is an investigational once-nightly formulation of sodium oxybate for the treatment of excessive daytime sleepiness (EDS), and cataplexy in narcolepsy patients. Its Micropump allows for the development of modified and/or controlled release solid, oral dosage formulations of drugs. Its LiquiTime technology allows for development of modified/controlled release oral products in a liquid suspension formulation, which may make such formulations particularly suited for children and/or patients having issues swallowing tablets or capsules. Its Medusa technology allows for the development of extended-/modified-release injectable dosage formulations of drugs.

This security is an American depositary receipt
ADR Fees
American Depositary Receipt (ADR) Fee

ADR fees charged by custodial banks normally average from 1 to 3 cents per share. Other country fees might apply. To read more, see the Exception Fees tab at Brokerage Fees

Price
Delayed
$7.23
Day's Change
-0.08 (-1.09%)
Bid
--
Ask
--
B/A Size
--
Day's High
7.53
Day's Low
6.89
Volume
(Heavy Day)

Today's volume of 1,335,284 shares is on pace to be much greater than AVDL's 10-day average volume of 783,202 shares.

1,335,284
  • Prev Close
    7.31
  • Today's Open
    7.53
  • Day's Range
    6.89-7.53
  • Avg Vol (10-day)
    783.2K
  • Last (time)
    3:38p ET 08/10/22
  • Last (size)
    100
  • 52-Wk Range
    1.05 - 11.59
    LowHigh
  • (11/15/21 - 05/26/22)
    37.62%
  • 171.6%
  • Market Cap
    425.4M
  • Shares Outstanding
    59.0M
  • -1.54
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.5
  • 57.98
  • (% of float 07/15/22)
    9.76

Latest News

August 09, 2022
7:00 am ET
Globe Newswire
August 02, 2022
11:53 am ET
Globe Newswire
July 19, 2022
8:30 am ET
PR Newswire
7:00 am ET
Globe Newswire
July 08, 2022
9:31 am ET
PR Newswire
June 29, 2022
4:05 pm ET
Globe Newswire
June 15, 2022
2:17 pm ET
Newsfile
June 13, 2022
8:38 pm ET
Globe Newswire
June 11, 2022
9:55 pm ET
Accesswire
June 08, 2022
9:23 pm ET
PR Newswire
June 06, 2022
9:22 pm ET
Newsfile
June 04, 2022
7:28 pm ET
Globe Newswire
June 03, 2022
8:00 am ET
Globe Newswire
June 02, 2022
5:05 pm ET
Accesswire
8:00 am ET
Globe Newswire
May 30, 2022
5:14 pm ET
PR Newswire
May 27, 2022
8:30 am ET
PR Newswire
May 26, 2022
9:09 am ET
MarketWatch
May 19, 2022
8:00 am ET
Globe Newswire
May 18, 2022
8:00 am ET
Globe Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.